These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6009727)

  • 1. [Specific substance in the urine of patients with collagen disease with special reference to collagen disease and phenylalanine and tyrosine metabolism].
    Nishimura N
    Rinsho Byori; 1966 Nov; 14(11):713-9. PubMed ID: 6009727
    [No Abstract]   [Full Text] [Related]  

  • 2. Intermediary metabolism of phenylalanine and tyrosine in diffuse collagen diseases. II. Influences of the low phenylalanine and tyrosine diet upon patients with collagen disease.
    NISHIMURA N; OKAMOTO H; YASUI M; MAEDA K; OGURA K
    Arch Dermatol; 1959 Oct; 80():466-77. PubMed ID: 14427316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tyrosine and 2,5-dioxyphenylpyruvic acid in patients with collagenoses and their clinical value].
    Kviatkovskaia AN; Kaĭnova AS; Mikhaĭlova IN
    Vrach Delo; 1966 Jan; 1():15-9. PubMed ID: 5974048
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylalanine and tyrosine in collagen diseases. Urinary excretion of general intermediary metabolites of tyrosine in patients with collagen disease and liver disease.
    NISHIMURA N; MAEDA K; YASUI M; OKAMOTO H; MATSUNAKA M; TOSHINA H
    Arch Dermatol; 1961 Apr; 83():644-52. PubMed ID: 13729226
    [No Abstract]   [Full Text] [Related]  

  • 5. Monitoring phenylalanine-tyrosine metabolism by high-resolution liquid chromatography of urine.
    Mrochek JE; Dinsmore SR; Ohrt DW
    Clin Chem; 1973 Aug; 19(8):927-36. PubMed ID: 4720815
    [No Abstract]   [Full Text] [Related]  

  • 6. [Peculiarities of amino acid metabolism in collagen diseases in children].
    Dorofeieva GD
    Pediatr Akus Ginekol; 1970; 1():16-7. PubMed ID: 5529374
    [No Abstract]   [Full Text] [Related]  

  • 7. [On the excretion of homovanillic acid in urine in malignant melanoma].
    Schwartze G; Conradi G
    Hautarzt; 1966 Aug; 17(8):348-51. PubMed ID: 5987526
    [No Abstract]   [Full Text] [Related]  

  • 8. Phenylalanine and tyrosine metabolism in patients with phenylketonuria.
    BOSCOTT RJ; BICKEL H
    Biochem J; 1953 Oct; 56(322nd Meeting):i. PubMed ID: 13126113
    [No Abstract]   [Full Text] [Related]  

  • 9. [Phenylpyruvate and o-hydroxyphenylacetate in the urine of phenylketonurics treated by dietary measures].
    Zelnícek E; Podhradská O; Sláma J
    Z Kinderheilkd; 1970; 108(3):258-64. PubMed ID: 5475034
    [No Abstract]   [Full Text] [Related]  

  • 10. [Activity of ACTH in the intermediate metabolism of tryptophan and tyrosine in normal and pathological conditions (with special reference to collagen diseases)].
    MOM AM; UBALTON SP; DEGANO I
    Rev Argent Endocrinol Metab; 1959; Suppl 2():33-53. PubMed ID: 14423476
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on urinary phenolic compounds in man. IV. O-Tyrosine and its metabolites.
    Gjessing LR; Borud O
    Scand J Clin Lab Invest; 1966; 18(2):221-6. PubMed ID: 5914748
    [No Abstract]   [Full Text] [Related]  

  • 12. [Excretion of parahydroxymandelic acid in collagen diseases].
    Ambanelli U; Giannini A
    Reumatismo; 1972; 24(2):128-31. PubMed ID: 4681334
    [No Abstract]   [Full Text] [Related]  

  • 13. [Tyrosinosis].
    Pospísil R; Mrskos A; Podhradská O; Hlavon J; Kaniová V; Saxl O
    Cesk Pediatr; 1974 Jan; 29(1):29-31. PubMed ID: 4452135
    [No Abstract]   [Full Text] [Related]  

  • 14. On the brain barrier system function and changes of cerebrospinal fluid concentrations of phenylalanine and tyrosine in human phenylketonuria.
    Ratzmann GW; Grimm U; Jährig K; Knapp A
    Biomed Biochim Acta; 1984; 43(2):197-204. PubMed ID: 6732755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Metabolic disorders of phenylalanine and tyrosine].
    Tsukada Y; Noguchi T
    Shinkei Kenkyu No Shimpo; 1965 Jul; 9(2):217-26. PubMed ID: 5893868
    [No Abstract]   [Full Text] [Related]  

  • 16. Tyrosine metabolism in connective tissue disease. Studies on unidentified phenolic and fluorescent compounds in the urine of patients with rheumatoid arthritis. I. Additional properties of the specific spot on paper chromatography.
    Nishimura N; Mori Y; Matsunaka M; Matoba S; Kawasaki H; Isobe S; Yamaguchi M; Matsukawa S
    Wakayama Med Rep; 1966 Jun; 11(1):1-14. PubMed ID: 5981386
    [No Abstract]   [Full Text] [Related]  

  • 17. Biochemical study of malnutrition. Part V. Metabolism of phenylalanine and tyrosine.
    Antener I; Verwilghen AM; van Geert C; Mauron J
    Int J Vitam Nutr Res; 1981; 51(3):297-306. PubMed ID: 6119298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of disorders of metabolism of phenylalanine-tyrosine.
    Bamshad J
    Mo Med; 1971 Jun; 68(6):382-5. PubMed ID: 5568001
    [No Abstract]   [Full Text] [Related]  

  • 19. Disorders associated with the metabolism of phenylalanine and tyrosine.
    KRETCHMER N; ETZWILER DD
    Pediatrics; 1958 Mar; 21(3):445-75. PubMed ID: 13542090
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of ionizing radiation on the metabolism of tyrosine and phenylalanine in irradiated plants].
    Kuzin AM; Fomenko BS; Medvedev AI
    Radiobiologiia; 1968; 8(5):736-41. PubMed ID: 5731682
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.